What are Neutralizing Antibodies? - News-Medical.net

-

A neutralizing antibody (NAb) is an antibody that is responsible for defending cells from pathogens, which are organisms that cause disease. They are produced naturally by the body as part of its immune response, and their production is triggered by both infections and vaccinations against infections.

Antibodies killing virus

Image Credit: Design_Cells/Shutterstock.com

Neutralizing antibodies can result in lifelong immunity to certain infections and can be used to see if a person has developed immunity to an infection after they have recovered from it.

Neutralizing antibodies can be confused with binding antibodies, which are responsible for binding to a pathogen and alerting the immune system to its presence so white blood cells can be sent to destroy it. Neutralizing antibodies, although an integral part of the body's immune response, serve a different purpose to binding antibodies.

How are neutralizing antibodies made?

Antibodies are made by B-cells in the bone marrow. When B-cells are created, they begin to produce antibodies that will bind to specific antigens.

How neutralizing antibodies work

A neutralizing antibody can stop a pathogen from infecting the body by affecting how the molecules on the pathogen's surface can enter cells in the body.

In enveloped viruses (a heat-sensitive virus cell that is inside a lipid membrane), neutralizing antibodies block the attachment of a virus to the cell as well as its entry into the cell.

In non-enveloped viruses (a heat-resistant virus-cell with no lipid membrane), neutralizing antibodies can bind to the capsid protein, which is the protein shell that surrounds the genetic information within a virus cell.

Neutralizing antibodies can also stop pathogens from changing their structure and shape, known as conformational changes, in order to enter and replicate within a cell.

In bacterial infections, neutralizing antibodies can block the harmful effects of toxins. This has been shown to happen in diphtheria medications, although they are no longer recommended to prevent diphtheria infections.

Once a pathogen has been neutralized by a NAb, the pathogen is degraded by white blood cells, and the spleen filters the pathogen for it to then be excreted through urine or feces.

Applications for neutralizing antibodies

A common use for neutralizing antibodies in medicine is in passive immunization. This is the process in which a person who is not immune to disease is given antibodies from a person who is already immune to the disease.

This protection does not last long, but it does protect and fight against infection immediately. Passive immunity can be passed on naturally through breastfeeding for the first few months of a baby's life.

Vaccination also makes use of neutralizing antibodies, which is known as active immunization. Vaccines are designed to mimic a natural immune response to an infection by injecting an active specimen of a virus or bacteria or part of a virus or bacteria into the body.

The immune system can be triggered to produce neutralizing antibodies in response to the virus or bacteria in the vaccine, which will then recognize and fight the infection naturally if the person is exposed to the pathogen for a second time.

How viruses evade neutralizing antibodies

Some viruses can evade the effects of neutralizing antibodies, such as the dengue virus and the Zika virus. The influenza virus is also able to evade neutralizing antibodies because it regularly mutates so that it is no longer recognized by antibodies, even though these antibodies may have recognized a previous strain of the influenza virus.

A process known as antibody-dependent enhancement (ADE), which leads to more severe infections, can take place when a virus binds to antibodies that help the virus infect cells. The virus is better able to enter into cells in the body and is sometimes more able to replicate once it has entered a host cell.

There are several ways by which antibody-dependent enhancement could take place.

In Dengue virus, neutralizing antibodies have been found to bind to a type of white blood cell known as a macrophage that helps the virus enter those white blood cells and replicate.

Additionally, proteins on the surface of a virus can be covered with antibodies that fight one serotype of a virus and can bind to a separate, similar virus with a different serotype.

The combination of the virus and antibodies then bind to the Fc-region antibody receptors (proteins that play a part in the protective role of the immune system) found on the cell membrane.

As a result, the cell is then able to internalize the virus and go on to replicate it, leading to enhanced infection.

Antibody-dependent enhancement has been seen in the following viruses:

  • Dengue virus
  • Yellow fever virus
  • Zika virus
  • Human immunodeficiency virus (HIV)
  • Coronaviruses affecting both humans and animals

ADE is a cause for concern in the development of vaccines. This is because vaccines often trigger the production of antibodies that could then facilitate ADE and cause more severe illness.

For instance, vaccinations against Dengue virus and a coronavirus affecting cats were deemed unsuccessful because they resulted in antibody-dependent enhancement that made the infection worse in those that had been vaccinated when compared to those that had not been vaccinated.

Zika Virus

Image Credit: Kateryna Kon/Shutterstock.com

Summary

Neutralizing antibodies are naturally occurring antibodies that play an important role in the immune system. They work alongside binding antibodies that signal the presence of a pathogen in the body so that white blood cells can locate and kill it.

Neutralizing antibodies are responsible for blocking the entry of a pathogen into a cell so that it is firstly unable to infect healthy cells, and secondly, it is unable to replicate and cause severe infection.

Neutralizing antibodies have found application in medicine and are often used as part of vaccines, but they have been found to help viruses enter cells and replicate to cause severe infections, and as such ensuring that neutralizing antibodies will not facilitate infection is an important part of developing vaccines.

References

  • An, Z., et al. Antibody therapies for the prevention and treatment of viral infections. (2017). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627241/
  • Bhattacharya, J., Ringe, R. Preventative, and therapeutic applications of neutralizing antibodies to human immunodeficiency virus type 1 (HIV-1). (2013). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967664/
  • Feldmann, H., et al. Antibody-dependent enhancement of Ebola virus infection. (2003).  https://jvi.asm.org/content/77/13/7539
  • Forthal, D. N. Functions of antibodies. (2014). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159104/
  • History of Vaccines. (2018). https://www.historyofvaccines.org/content/articles/passive-immunization
  • Klasse, P. J. Neutralization of virus infectivity by antibodies: old problems in new perspectives. (2014). https://www.hindawi.com/journals/ab/2014/157895/
  • PNAS. (2020). https://www.pnas.org/content/117/15/8218
  • Virology. (2009). https://www.virology.ws/2009/07/24/virus-neutralization-by-antibodies/

Further Reading

Comments

Post a Comment

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

-
Image
sores inside the mouth and ear aches :: Article Creator Mouth Sores: Symptoms, Treatment, And Prevention Mouth sores may look different depending on the cause, appearing a different color than the surrounding tissue, including white, yellow, red, or purple. The following images show different types of mouth sores. These images are not intended to provide a diagnosis. If you have unexplained mouth sores or mouth sores that come back or last for a long time, it is best to visit a doctor for a diagnosis and treatment. Canker sores Canker sores may look like small oval-shaped ulcers in your mouth that appear white, gray, or yellow. They may be surrounded by a red "halo" of irritation. They may also appear as a painful red area. Canker sores are also called aphthous stomatitis or aphthous ulcers. They are common and affect about 25% of the general population. They are usually harmless and heal on their own in a couple of weeks. I...
Read more

Outer Ear: Anatomy, Location, and Function - Verywell Health

-
Image
There is much more to the ear than what you see from the outside. There are three parts to the ear—the outer ear, the middle ear, and the inner ear. These sections work together to collect sound from the world around you and send it to the brain where speech and auditory centers translate the information. The outer ear is the part of the ear that you can see and where sound waves enter the ear before traveling to the inner ear and brain. While the outer ear may not be as complex as its counterparts, it serves a vital function in your sense of hearing. AndreiDavid / Getty Images Anatomy Structure The outer ear—sometimes called the auricle or pinna—is mostly made of skin and cartilage.   It is made up of several components:   Helix: The outermost curvature of the ear, extending from where the ear joins the head at the top to where it meets the lobule. The helix begins the funneling of sound waves into the ear Fossa, superior crus, inferior crus, and...
Read more

Chalazion (cyst): Symptoms, pictures, causes, and treatment

-
Image
conjunctival pemphigoid :: Article Creator Modulating Conjunctival Wound Healing Thylefors B, Negrel A . The global impact of glaucoma. Bull World Health Org 1994;72:323–6 CAS  PubMed  PubMed Central  Google Scholar  Foster A, Johnson G . Magnitude and causes of blindness in the developing world. Int Ophthalmol 1990;14:135–40 Article  CAS  PubMed  Google Scholar  Quigley H . Number of people with glaucoma worldwide [see comments]. Br J OphthalmoI 1996;80:389–93 Article  CAS  Google Scholar  Sommer A . Glaucoma: facts and figures. Doyne Lecture. Eye 1996;10:295–301 Article  PubMed  Google Scholar  Jay J . Rational choice of therapy in primary open angle glaucoma. Eye 1992;6:243–7 Article  PubMed  Google Scholar  Migdal C, Gregory W, Hitchings R Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophtha...
Read more